Charlotte's Web Holdings (CWBHF) Change in Accured Expenses (2021 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Change in Accured Expenses of -$537000.0 for Q1 2026, down 161.87% year-over-year from $868000.0 in Q1 2025, and up 83.79% quarter-over-quarter from -$3.3 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Change in Accured Expenses for 6 consecutive years, with -$537000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 161.87% year-over-year to -$537000.0; the TTM figure through Mar 2026 stood at -$2.5 million (down 163.48% YoY), while the FY2025 annual figure was -$1.1 million, down 129.24% from the prior year.
- Change in Accured Expenses rose to -$537000.0 in Q1 2026 per CWBHF's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $5.0 million in Q4 2024 and bottomed at -$3.6 million in Q4 2022.
- Historically, Change in Accured Expenses has averaged -$83000.0 across 5 years, with a median of $33000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 344.32% — and 2024, when it jumped 280.47%.
- Charlotte's Web Holdings' Change in Accured Expenses stood at -$3.6 million in 2022, then rose by 22.7% to -$2.8 million in 2023, then surged by 280.47% to $5.0 million in 2024, then tumbled by 166.37% to -$3.3 million in 2025, then soared by 83.79% to -$537000.0 in 2026.
- Business Quant data shows CWBHF's Change in Accured Expenses at -$537000.0 in Q1 2026, -$3.3 million in Q4 2025, and $752000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Charlotte's Web Holdings | 62.78 Mn | 48.79 Mn | 5.16 Mn | 528,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 528,000.00 |
| Jun 30, 2026 | 528,000.00 |
| Mar 31, 2026 | -537,000.00 |
| Mar 31, 2026 | -537,000.00 |
| Dec 31, 2025 | -3.31 Mn |
| Dec 31, 2025 | -3.31 Mn |
| Sep 30, 2025 | 752,000.00 |
| Sep 30, 2025 | 752,000.00 |
| Jun 30, 2025 | 603,000.00 |
| Jun 30, 2025 | 603,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 4.99 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | -980,000.00 |
| Sep 30, 2024 | -980,000.00 |
| Jun 30, 2024 | -949,000.00 |
| Jun 30, 2024 | -949,000.00 |
| Mar 31, 2024 | 663,000.00 |
| Mar 31, 2024 | 663,000.00 |